The nation’s top pharmacy benefit manager (PBM) lobbying group is going on the offensive, stepping up its advocacy efforts against the pharmaceutical industry after Congress passed a PBM industry overhaul last winter. The pharmaceutical industry spent years pointing fingers at pharmacy benefit managers as the reason for high drug costs, and Congress finally was able...
The nation’s top pharmacy benefit manager (PBM) lobbying group is going on the offensive, stepping up its advocacy efforts against the pharmaceutical industry after Congress passed a PBM industry overhaul last winter. The pharmaceutical industry spent years pointing fingers at pharmacy benefit managers as the reason for high drug costs, and Congress finally was able...
<iframe src="https://statesidedaily.com/embed/cluster/043fe10b718429ec29da41b67a15da29fb916f21" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="PBM lobby goes on the offensive"></iframe>
